Gastro-oesophageal reflux disease: Impact of guidelines on GP management

Australian Family Physician

Volumn 37, Issue 1-2, 2008, Pages 73-77

  Kirby, Catherine N ^a   Piterman, Leon ^a   Nelson, Mark R ^b   Dent, John ^c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; AUSTRALIA; GASTROESOPHAGEAL REFLUX; GENERAL PRACTICE; HUMAN; MEDICAL AUDIT; METHODOLOGY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

ANTACIDS; AUSTRALIA; FAMILY PRACTICE; GASTROESOPHAGEAL REFLUX; GUIDELINE ADHERENCE; HISTAMINE H2 ANTAGONISTS; HUMANS; MEDICAL AUDIT; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 40649129536     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Dent J, El-Serag H, Wallander M, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-7.
2. Britt H, Miller G, Knox S, et al. General practice activity in Australia 2002-03. Canberra: Australian Institute of Health and Welfare, 2003. Report No.: AIHW cat. no. GEP 14.
3. Gastroenterological Society of Australia. Gastro-oesophageal reflux disease in adults: guidelines for clinicians, 2001. 3rd edn. Available at www.gesa.org.au/members_guidelines/goreflux/index.htm.
4. Britt H, Miller GC, Charles J, et al. General Practice activity in Australia 1999-2000. Canberra: Australian Institute of Health and Welfare, 2000. Report No.: AIHW cat. no. GEP 5.
5. Britt H, Miller GC, Henderson J, Bayram C. Patient-based substudies from BEACH: abstracts and research tools 1999-2006. Canberra: Australian Institute of Health and Welfare, 2007. Report No.: AIHW cat. no. GEP 20.
6. Buchan H, Sewell JR, Sweet M. Translating evidence into practice. Med J Aust 2004;180:S43-4.
7. Rawlins M. In the pursuit of quality: the National Institute for Clinical Excellence. Lancet 1999;353:1079-82.